Vyne Therapeutics Stock Forecast - Relative Strength Index
| VYNE Stock | USD 2.89 0.06 2.03% |
Vyne Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Vyne Therapeutics stock prices and determine the direction of Vyne Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Vyne Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Vyne |
| Check Vyne Therapeutics Volatility | Backtest Vyne Therapeutics | Information Ratio |
Vyne Therapeutics Trading Date Momentum
| On November 26 2024 Vyne Therapeutics was traded for 2.89 at the closing time. The top price for the day was 2.93 and the lowest listed price was 2.77 . The trading volume for the day was 95.9 K. The trading history from November 26, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.35% . |
| Compare Vyne Therapeutics to competition |
Other Forecasting Options for Vyne Therapeutics
For every potential investor in Vyne, whether a beginner or expert, Vyne Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vyne Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vyne. Basic forecasting techniques help filter out the noise by identifying Vyne Therapeutics' price trends.Vyne Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vyne Therapeutics stock to make a market-neutral strategy. Peer analysis of Vyne Therapeutics could also be used in its relative valuation, which is a method of valuing Vyne Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Vyne Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vyne Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vyne Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Vyne Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Vyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Vyne Therapeutics stock market strength indicators, traders can identify Vyne Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 5238.77 | |||
| Daily Balance Of Power | (0.38) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 2.85 | |||
| Day Typical Price | 2.86 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | (0.06) |
Vyne Therapeutics Risk Indicators
The analysis of Vyne Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vyne Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vyne stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.2 | |||
| Semi Deviation | 2.86 | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.11 | |||
| Downside Variance | 12.57 | |||
| Semi Variance | 8.17 | |||
| Expected Short fall | (4.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vyne Therapeutics is a strong investment it is important to analyze Vyne Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vyne Therapeutics' future performance. For an informed investment choice regarding Vyne Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Vyne Therapeutics to cross-verify your projections. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 1.72 | Revenue Per Share 0.016 | Quarterly Revenue Growth 0.467 | Return On Assets (0.35) | Return On Equity (0.60) |
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.